Lennox-Gastaut syndrome gene therapy (Encoded Therapeutics)

N/A

Report date: 2024/05/30 17:46:52

Base Information

Drug NameLennox-Gastaut syndrome gene therapy (Encoded Therapeutics)
Drug Alias NameGABAergic gene therapy (Encoded Therapeutics)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsLennox Gastaut SyndromeEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEncoded Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEncoded Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLennox Gastaut SyndromeEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A